Cited by 87Growth Hormone and Insulin-like Growth FactorsTraumatic Brain Injury ResearchTraumatic Brain Injury and Neurovascular Disturbances

Growth hormone (GH) and brain trauma

Devesa, Jesús, Reimunde, Pedro, Devesa, Pablo, Barberá, Matías, Arce, Víctor·2013·Hormones and Behavior

Abstract

Growth hormone (GH) is a pleiotropic hormone with known neurotrophic effects. We aimed to study whether GH administration might be useful together with rehabilitation in the recovery of TBI patients. 13 TBI patients (8 M, 5 F; age: 6-53 years old) were studied. Time after TBI: 2.5 months to 11 years; 5 patients showed acquired GH-deficiency (GHD). Disabilities observed: cognitive disorders; motor plegias; neurogenic dysphagia (n=5), vegetative coma (n=2) and amaurosis (n=1). All but one TBI patient followed intense rehabilitation for years. Treatment consisted of GH administration (maximal dose 1 mg/day, 5 days/week, resting 15-days every 2-months, until a maximum of 8 months) and clinical rehabilitation according to the individual needs (3-4 h/day, 5 days/week, during 6-12 months). Informed consent was obtained before commencing GH administration. GH significantly increased plasma IGF-1 values (ng.mL(-1)) in both GHD and no GHD patients, being then similar between both groups (GHD: 275.6±35.6 [p<0.01 vs. baseline], no GHD: 270.2±64 [p<0.05 vs. baseline]). In all the cases clear significant improvements were observed during and at the end of the combined treatment. Cognitive improvements appeared earlier and were more important than motor improvements. Swallowing improved significantly in all TBI patients with neurogenic dysphagia (2 of them in a vegetative state). Visual performance was ameliorated in the patient with amaurosis. No undesirable side-effects were observed. Our data indicate that GH can be combined with rehabilitation for improving disabilities in TBI patients, regardless of whether or not they are GHD.

Integrity signals

Registry

Crossref · 10.1016/j.yhbeh.2012.02.022

Cites

101 of 101 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Early recognition and intervention, including hormone replacement when appropriate, may improve neurocognitive recovery and overall rehabilitation outcomes after pediatric TBI.

    “Early recognition and intervention, including hormone replacement when appropriate, may improve neurocognitive recovery and overall rehabilitation outcomes.”
  • Devesa et al. found that GH treatment combined with rehabilitation in 13 TBI patients, 5 of whom had acquired GHD, produced substantial cognitive improvements, with cognitive function recovery occurring more rapidly and significantly than motor function recovery.

    “For instance, Devesa et al. studied the effects of GH treatment in combination with rehabilitation in 13 TBI patients, 5 of whom had acquired GHD. Their findings revealed substantial cognitive improvements, with cognitive function recovery occurring more rapidly and significantly compared to motor function recovery [33].”
  • GH may facilitate the proliferation, differentiation, and survival of new neurons in response to brain injury.

    “Based on the experimental evidence, it was hypothesized that GH may facilitate the proliferation, differentiation, and survival of new neurons in response to brain injury (191,192).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Devesa, J., Reimunde, P., Devesa, P., Barberá, M., & Arce, V.
Affiliations
  • Universidade de Santiago de Compostela (ES)
  • Universidade da Coruña (ES)
Corresponding author
Devesa, Jesús
Venue
Hormones and Behavior
Publisher
Elsevier BV
Published
2013-02
Volume
63
Issue
2
Pages
331-344
ISSN
0018-506X (ISSN-L)
OpenAlex
W2007129533
Cited by
87
References
101
Citations by year
2026: 3 · 2025: 4 · 2024: 3 · 2023: 2 · 2022: 8 · 2021: 7 · 2020: 6 · 2019: 8 · 2018: 13 · 2017: 8 · 2016: 9 · 2015: 4 · 2014: 5 · 2013: 5 · 2012: 1
FWCI
3.85
Type
journal article
Language
en
Open access
closed
Locations
  • Hormones and Behavior (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
  • Health Sciences › Medicine › Epidemiology › Traumatic Brain Injury Research
  • Health Sciences › Medicine › Neurology › Traumatic Brain Injury and Neurovascular Disturbances
Keywords
growth hormone therapy, traumatic brain injury, rehabilitation, insulin-like growth factor I, neurotrophic effects, cognitive recovery, motor recovery, neurogenic dysphagia, visual impairment
MeSH terms
Accidents, Traffic, Adolescent, Adult, Animals, Brain Injuries, Child, Female, Humans, Male, Middle Aged, Growth Hormone, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review